Teen pregnancy continues to plague the United States. This review will discuss long-acting reversible contraceptive (LARC) method use in teens, comprising intrauterine devices and subdermal implants.
INTRODUCTION
Adolescents are among the highest risk group for unintended pregnancy, yet are using some of the least effective methods of contraception. Although progress has been made, and rates are beginning to decline, the United States continues to lead developed nations with the highest rates [1 & ,2 & ]. The recent decline in adolescent birth rates has largely been attributed to increasing use of contraception [3] . Long-acting reversible contraception (LARC), including intrauterine devices (IUDs) and the subdermal implant, are among the most effective methods of reversible contraception, but traditionally have not been offered to the adolescent population. Recent changes in practice are reflective of an evolution of our understanding of these methods. Increasing uptake of intrauterine contraception and subdermal contraceptive implants in the adolescent population has the potential to reduce teen pregnancy rates.
Is there a need?
Almost 750 000 teens become pregnant each year, resulting in a US teen pregnancy rate of 7% in 2006 [2 & ]. Despite the fact that sexual behaviors and practices among US teens are similar to those of other developed nations, pregnancy rates are not. European teens are more likely to use contraception, especially the more effective methods, which are reflected in a US teen pregnancy rate that is threefold greater than Sweden, and four-fold greater than France [4, 5] . Although the majority of teens report using contraception during their first sexual experience, most are relying on condoms. Only 20% of sexually active female adolescents report using both barrier methods and hormonal methods simultaneously [6 & ], with another 19% reporting no contraceptive use [7] .
Across all ages, contraceptive methods that are coital or user dependant (condoms, pills, patch, ring, injections) have higher typical use failure rates (Table 1) [8] . LARC methods have perfect and typical use failure rates that rival permanent sterilization, and are clearly more appropriate in an adolescent population with decades of fertility ahead of them. Adolescents are at even higher risk of inconsistent contraceptive use than are other populations. In fact, a recent New England Journal publication demonstrated a two-fold increased risk of contraceptive failure in women less than 21 years of age using the pill, patch, or ring, compared with older women [9 && ]. In this study, adolescents had similar, low failure rates with LARC methods as women 21 years of age and older. LARC methods are user independent, and therefore require no effort by the patient after initial insertion. This results in essentially equal typical and perfect use failure rates [8] .
Currently available long-acting reversible contraception
LARC methods include intrauterine devices and the subdermal implant. There are very few contraindications to LARC methods. Each LARC method requires a clinician visit for insertion and removal. Although this can be viewed as a barrier to access in some populations, in the adolescent population it affords the healthcare team an opportunity for screening, intervention, and counseling specifically related to making healthy choices about sexual activity, condom use, sexually transmitted infection (STI) prevention, and other preventive services.
THE INTRAUTERINE DEVICE
There are currently two IUDs available in the United States: the levonorgestrel intrauterine system (LNG-IUS) and the Copper T380A IUD. It is a myth that an IUD should be inserted during a woman's menses. In fact, an IUD can be inserted at any point in the menstrual cycle if pregnancy can be reliably ruled out. Additionally, an IUD can be placed immediately following delivery or abortion [10] .
The LNG-IUS is a T-shaped polyethylene frame containing 52 mg of levonorgestrel which is released at a rate of 20 mg per day for 5 years after which time the daily dose drops by approximately 50% [11] . The LNG-IUS prevents pregnancy through a combination of mechanisms, but mainly through prevention of fertilization. The hormonal component thickens cervical mucus inhibiting sperm motility and capacitation, as well as thinning the endometrial lining eliciting a foreign body reaction. In some women, ovulation may be suppressed [12] . The LNG-IUS has many noncontraceptive benefits that make it appealing to adolescents. Average monthly blood loss can decrease by up to 90%, with 20-40% of users becoming amenorrheic by 1 year of use [13] [14] [15] . In addition, the LNG-IUS reduces painful menses (dysmenorrhea).
The CuT380A IUD is a T-shaped, nonhormonal, polyethylene frame wrapped in copper wire (surface area of copper ¼ 380/mm 2 ). Pregnancy prevention with this method is primarily through inhibition of fertilization. The copper ions appear to be spermicidal [16] . The CuT380A can also be used as emergency contraception within 5 days following unprotected intercourse. It is a nonhormonal method, and has been consistently shown to have rapid return to fertility [17, 18] . Because of the potential to use this method for up to 10 years, this is one of the most cost-effective contraceptive options [19] . Despite these advantages, the CuT380A is chosen less often than the LNG-IUS by adolescents, because it does not improve menorrhagia or dysmenorrhea. In fact, in some women these symptoms may worsen with copper IUD use [12] .
In addition to providing excellent contraception, prevention of endometrial cancer [17, 18, 20] and cervical cancer [21 & ] has also been suggested benefits of both the CuT380A and the LNG-IUS. Endometrial cancer is thought to be prevented through both inflammatory response created by
KEY POINTS
LARC is a safe and effective method of pregnancy prevention in adolescents.
Adolescent users of LARC have 12-month continuation rates and high levels of satisfaction.
There are many myths related to intrauterine devices limiting more widespread use. the IUD as well as prevention of endometrial proliferation in the case of the LNG-IUS [22, 23] . The mechanism by which cervical cancer may be prevented is less understood, but increased cellular immunity initiated by the device is one leading theory.
SUBDERMAL ETONOGESTREL IMPLANT
There is only one contraceptive implant available in the United States, the etonogestrel-releasing (ENG) subdermal implant. The current implant (Implanon) will soon be replaced by Nexplanon, which is identical to Implanon, but contains barium for radiographic identification. In addition, Nexplanon has a new inserter mechanism. The ENG implant is a single rod, progestin-only implant that measures 4 cm in length and 2 mm in diameter. Similar to the IUD, the ENG implant provides excellent contraceptive effectiveness. It is approved for 3 years of use; however, two small studies of 75-200 patients reported zero pregnancies in the fourth year of use [24, 25] . This device works predominantly through ovulation inhibition as well as thickening of cervical mucus and thinning of the endometrial lining. The ENG implant has been popular among the adolescent population within the Contraceptive CHOICE Project in Saint Louis, Missouri. The CHOICE Project is an ongoing prospective cohort study designed to increase LARC uptake by eliminating financial and knowledge barriers. The project has enrolled 9256 women, of which more than 5500 are younger than the age of 25 years. Among the first 658 adolescents enrolled, 64% chose a LARC method at baseline, and among those LARC users age 14-17 years, 63% chose the implant [26 && ]. There are many features of the ENG implant that make it appealing to younger age groups. The contraceptive effectiveness is outstanding, and it requires 'no maintenance.' Other than remembering that its FDA-approved duration is 3 years, the method is 'forgettable.' In addition, the ENG implant has been shown to improve acne and relieve dysmenorrhea, both of which are fairly common in adolescents [27] . Because the device is inserted in the arm under local anesthesia, adolescents can avoid the pelvic exam and IUD insertion; which many teens experience as anxiety provoking and potentially painful. There are some disadvantages to the implant. The main disadvantage reported is unscheduled or unpredictable bleeding [12] . Bleeding patterns can range from amenorrhea to daily spotting or heavy flow; there is no way to predict the pattern of individual users. Some providers have suggested nonsteroidal antiinflammatory agents (NSAIDs), doxycycline, or lowdose oral contraceptives to control bleeding in teens that are experiencing undesirable, irregular bleeding [28] . However, there is limited evidence to support these practices.
Common misconceptions
One misconception surrounding the IUD that has limited its use in the adolescent population is that IUDs cause pelvic inflammatory disease (PID) and infertility. The American College of Obstetricians and Gynecologists has published a committee opinion on IUDs in adolescents and notes that IUDs do not increase an adolescent's risk of PID, STI, or infertility [29] . Because adolescents and young adults contribute the majority of incident cases of STIs, testing for Neisseria gonorrhoeae and Chlamydia trachomatis should be performed in sexually active adolescents at the time of insertion or prior to insertion, and IUD insertion should be delayed if evidence of frank mucopurulent discharge or cervicitis are noted on exam. There is no need to delay insertion until STI test results are available. Testing at the time of insertion will allow for expedited treatment and significant reduction in the transient increased risk of infection associated with the peri-insertional period [30] . The slight increased risk of PID in the 20 days following IUD insertion (9.7 cases/1000 women-years) can further be minimized with careful insertion technique and re-emphasis on the importance of correct and consistent condom use [30] .
Many providers are concerned about expulsion rates among teens. Data about expulsion in the adolescent population is limited and inconsistent. Rasheed and Abdelmonem [31] found only seven expulsions in 244 adolescents using the CuT380A IUD for an overall rate of 2.9%. Another study found that among 141 parous adolescents receiving intrauterine contraception, 21 (14%) experienced an expulsion with no differences seen by IUD type [32] . Among the first 142 adolescents (age 14-20 years) that chose an IUD at enrollment into the CHOICE Project, 12-month expulsion rates were found to be 6.3% [33] . There are slightly more data available addressing expulsion in nulliparous women. One recent European study evaluating IUD insertion and use in 117 nulliparous women reported six expulsions at 1 year for an overall rate of 5.1% [34] . Experience in the CHOICE project has been similar. The 12-month expulsion rate of 437 IUDs placed in nulliparous participants was 4.1% [33] . Findings of these studies fall within the overall reported expulsion rates of 2-10% [12] .
Concern regarding satisfaction and continuation of IUDs in the adolescent population are also common. It should be emphasized that teens are more likely to discontinue ALL methods when compared with older women [35] . However, adolescents are less likely to discontinue LARC methods than non-LARC methods [36] . When anticipatory guidance is given prior to initiation of a method, and teens know what to expect, continuation, and satisfaction rates will be higher. Of the first 5087 participants enrolled in the Contraceptive CHOICE project, of which 68% were using a LARC method, continuation and satisfaction rates were greater than 80%. When stratified by age, adolescents (<20 years of age) continued to have high satisfaction and continuation rates for both the LNG-IUS and subdermal implant (>80%). Adolescents using the CuT380A had slightly lower continuation rates than did older women using this method (72 versus 85%). Continuation rates among adolescent CuT380A users, however, were still significantly higher than continuation rates among adolescent non-LARC users [37 && ].
Wait! don't do it: contraindications to long-acting reversible contraception
There are some instances in which a LARC method may not be recommended. The US Medical Eligibility Criteria for Contraceptive Use was developed in 2010 and can be referenced to provide information related to specific comorbidities (www.cdc.gov/mmwr/pdf/rr/rr5904.pdf) [38 && ]. Table 2 represents some of the more common conditions encountered in an adolescent population. For almost all conditions, the advantages of using the method outweigh the risks. There are, however, a few contraindications for the use of the IUD or implant (Table 3) [10, 39] .
Is insertion or removal more difficult in teens?
IUD discomfort or pain with IUD insertion is variable, with some women describing no or minimal pain, and others reporting severe pain. Advancements in pain management during IUD insertion have been lacking. Many interventions have been evaluated, but with disappointing results. NSAIDs have been shown to improve postprocedural cramping, but have not been shown to improve peri-insertional pain. Misoprostol for cervical priming and paracervical injection of local anesthetic have also failed to show improvement in pain scores [40, 41] . A recent Cochrane Review concluded that none of the properly evaluated interventions have been shown to improve peri-insertional pain [40] . The use of misoprostol to soften the cervix has been shown to increase ease of insertion as reported by the clinician; however, it has not been shown to improve pain perceived by the patient. In fact, misoprostol may cause more preinsertion discomfort related to the uterine contractile properties of the medication [42, 43] .
Implant insertion and removal of the ENGimplant is done in the office under local anesthesia. There are no special precautions or modifications to insertion or removal in adolescents.
ARE TEEN USERS SATISFIED WITH LONG-ACTING REVERSIBLE CONTRACEPTION OR ARE THEY STOPPING USE EARLY?
Continuation and satisfaction are important factors to consider in the adolescent population. Although LARC methods are among the most cost-effective reversible methods, they come with a high upfront cost. If teens are more likely to discontinue use of the method soon after initiation, it could be argued that the potential for wasted resources outweighs the benefits of the method. One study evaluating continuation in a parous adolescent population found a median continuation rate of 14.1 months for both IUD types [32] . More importantly, Behringer et al.
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&&
] did not find any differences in the rates of discontinuation secondary to dissatisfaction in adolescents (10.7%) versus older women (10.9%). The Contraceptive CHOICE Project noted that women using LARC methods were more satisfied than women using non-LARC methods. In addition, more than 85% of users were still using their LARC method at 12-month follow-up. Age did not significantly impact continuation rates in this analysis [30] .
CONCLUSION
Adolescents are among the highest risk group for unplanned pregnancy. Encouraging use of the most effective contraceptive methods has the potential to impact the high rate of teen pregnancy in the United States. The most effective contraceptive methods are those that are user independent. LARC methods, including intrauterine devices and the subdermal implant, are forgettable, safe in the adolescent population, have high rates of continuation and satisfaction, and are highly cost-effective. Family planning as a preventive service saves healthcare dollars [45 & ]. Clinicians, policy makers, and all individuals interested in reproductive health and prevention should advocate for no-cost contraception, including LARC methods, to all women, especially adolescents.
